4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-22-002467
Options or other derivatives
- Chief Business Officer acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Zimmermann Carolyne Chief Business Officer | 2022-02-01 | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | D | ||
Loading xslF345X03/doc1.xml…